RECENT ANALYSIS
Agency Launches Rare Disease Framework Initiative to Modernize Drug Development and Regulatory Review; Public Meeting on Oct. 28 and RFI to Follow
The Food and Drug Administration (FDA) announced the Rare Disease Framework Initiative to develop a more consistent, flexible and tailored approach to reviewing drugs and biologics for rare diseases. The initiative seeks to align regulatory expectations with the realities of rare disease development, including small patient populations, limited understanding of disease progression and challenges generating traditional clinical trial evidence. According… (Colocho, October 14, 2026) #Food and Drug Administration, #Prescription Drugs
CMS Gender-Affirming Care Federal Funding Restrictions Take Effect as States Work to Preserve Coverage
Today, the Centers for Medicare and Medicaid Services (CMS) final rule restricting federal Medicaid and Children’s Health Insurance Program (CHIP) funding for gender-affirming care took effect. The rule prohibits federal Medicaid matching funds from covering specified gender-affirming services, including puberty blockers, hormone therapy, and surgical interventions, for Medicaid enrollees under age 18 and CHIP enrollees under age 19 when provided… (Eisen, October 13, 2026) #Health Equity
Administration Announces More Than $6 Billion in Science Initiatives at Golden Age Summit
The White House announced more than $6 billion in federal, industry, academic, and philanthropic investments and commitments during its Science: A New Golden Age Summit. The initiatives focus on expanding access to artificial intelligence (AI), referred to by the administration as super intelligence (SI), for scientific research; supporting early-career scientists; advancing national research priorities; and developing new research institutions and… (Colocho, October 9, 2026) #Artificial Intelligence, #Grants, #Health Information Technology, #Workforce